HAE logo

Haemonetics (HAE) Shareholders Equity

Annual Shareholders Equity

$959.96 M
+$141.96 M+17.35%

31 March 2024

HAE Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$878.85 M
-$26.52 M-2.93%

28 September 2024

HAE Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HAE Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.4%-1.7%
3 y3 years+31.2%+20.3%
5 y5 years+43.7%+50.5%

HAE Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+31.2%-8.4%+25.8%
5 y5 yearsat high+63.5%-8.4%+53.0%
alltimeall timeat high+959.6%-8.4%+1097.3%

Haemonetics Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$878.85 M(-2.9%)
June 2024
-
$905.37 M(-5.7%)
Mar 2024
$959.96 M(+17.4%)
-
Mar 2024
-
$959.96 M(+1.8%)
Dec 2023
-
$943.32 M(+5.6%)
Sept 2023
-
$893.66 M(+3.4%)
June 2023
-
$864.62 M(+5.7%)
Mar 2023
$818.00 M(+9.2%)
$818.00 M(+5.4%)
Dec 2022
-
$775.98 M(+6.4%)
Sept 2022
-
$729.01 M(-5.4%)
June 2022
-
$770.42 M(+2.8%)
Mar 2022
$749.42 M(+2.4%)
$749.42 M(+2.6%)
Dec 2021
-
$730.77 M(+4.6%)
Sept 2021
-
$698.55 M(+3.2%)
June 2021
-
$677.08 M(-7.5%)
Mar 2021
$731.67 M(+24.6%)
$731.67 M(+1.7%)
Dec 2020
-
$719.15 M(+7.7%)
Sept 2020
-
$667.92 M(+9.8%)
June 2020
-
$608.57 M(+3.7%)
Mar 2020
$587.11 M(-12.1%)
$587.11 M(+2.2%)
Dec 2019
-
$574.58 M(-1.6%)
Sept 2019
-
$583.75 M(-1.2%)
June 2019
-
$590.97 M(-11.5%)
Mar 2019
$667.87 M(-11.2%)
$667.87 M(+3.8%)
Dec 2018
-
$643.13 M(-8.3%)
Sept 2018
-
$701.34 M(+4.0%)
June 2018
-
$674.06 M(-10.4%)
Mar 2018
$752.43 M(+1.7%)
$752.43 M(-8.6%)
Dec 2017
-
$822.81 M(+2.7%)
Sept 2017
-
$801.25 M(+3.7%)
June 2017
-
$772.77 M(+4.5%)
Mar 2017
$739.61 M(+2.5%)
$739.61 M(-4.1%)
Dec 2016
-
$770.90 M(+2.9%)
Sept 2016
-
$749.11 M(+4.7%)
June 2016
-
$715.56 M(-0.8%)
Mar 2016
$721.57 M(-12.7%)
$721.57 M(+0.3%)
Dec 2015
-
$719.55 M(-7.4%)
Sept 2015
-
$776.88 M(-1.9%)
June 2015
-
$791.65 M(-4.2%)
Mar 2015
$826.12 M(-1.4%)
$826.12 M(-0.9%)
Dec 2014
-
$833.91 M(+1.6%)
Sept 2014
-
$820.72 M(+0.7%)
June 2014
-
$815.07 M(-2.7%)
Mar 2014
$837.89 M(+8.9%)
$837.89 M(+1.5%)
Dec 2013
-
$825.22 M(+3.6%)
Sept 2013
-
$796.47 M(+2.9%)
June 2013
-
$774.38 M(+0.7%)
Mar 2013
$769.18 M(+5.0%)
$769.18 M(-1.3%)
Dec 2012
-
$779.16 M(+0.9%)
Sept 2012
-
$771.97 M(+1.9%)
June 2012
-
$757.47 M(+3.4%)
Mar 2012
$732.63 M(+6.8%)
$732.63 M(+3.9%)
Dec 2011
-
$705.23 M(+4.0%)
Sept 2011
-
$678.28 M(-4.8%)
June 2011
-
$712.46 M(+3.8%)
Mar 2011
$686.14 M(+15.7%)
$686.14 M(+5.8%)
Dec 2010
-
$648.52 M(+9.1%)
Sept 2010
-
$594.39 M(+5.2%)
June 2010
-
$564.96 M(-4.7%)
Mar 2010
$593.12 M(+9.9%)
$593.12 M(+3.5%)
Dec 2009
-
$573.08 M(-1.1%)
Sept 2009
-
$579.43 M(+2.8%)
June 2009
-
$563.85 M(+4.4%)
Mar 2009
$539.88 M(+9.2%)
$539.88 M(+4.7%)
Dec 2008
-
$515.79 M(+3.8%)
Sept 2008
-
$496.81 M(+0.6%)
June 2008
-
$493.93 M(-0.1%)
DateAnnualQuarterly
Mar 2008
$494.19 M(+3.0%)
$494.19 M(+4.3%)
Dec 2007
-
$473.70 M(+5.8%)
Sept 2007
-
$447.73 M(-6.0%)
June 2007
-
$476.56 M(-0.6%)
Mar 2007
$479.65 M(+8.9%)
$479.65 M(+5.8%)
Dec 2006
-
$453.34 M(-0.8%)
Sept 2006
-
$456.99 M(-1.0%)
June 2006
-
$461.83 M(+4.8%)
Mar 2006
$440.56 M(+24.1%)
$440.56 M(+5.2%)
Dec 2005
-
$418.97 M(+8.2%)
Sept 2005
-
$387.25 M(+3.9%)
June 2005
-
$372.57 M(+4.9%)
Mar 2005
$355.13 M(+26.9%)
$355.13 M(+5.7%)
Dec 2004
-
$335.94 M(+8.5%)
Sept 2004
-
$309.67 M(+5.1%)
June 2004
-
$294.63 M(+5.3%)
Mar 2004
$279.75 M(+25.3%)
$279.75 M(+5.9%)
Dec 2003
-
$264.23 M(+10.2%)
Sept 2003
-
$239.85 M(+3.2%)
June 2003
-
$232.44 M(+4.1%)
Mar 2003
$223.24 M(-5.7%)
$223.24 M(+0.9%)
Dec 2002
-
$221.26 M(+3.7%)
Sept 2002
-
$213.40 M(-2.5%)
June 2002
-
$218.77 M(-7.6%)
Mar 2002
$236.82 M(+9.9%)
$236.82 M(-7.4%)
Dec 2001
-
$255.87 M(+3.4%)
Sept 2001
-
$247.34 M(+5.1%)
June 2001
-
$235.24 M(+9.2%)
Mar 2001
$215.52 M(+6.3%)
$215.52 M(+7.1%)
Dec 2000
-
$201.21 M(+6.1%)
Sept 2000
-
$189.67 M(-9.2%)
June 2000
-
$208.86 M(+3.0%)
Mar 2000
$202.81 M(-8.6%)
$202.81 M(-4.4%)
Dec 1999
-
$212.10 M(-0.8%)
Sept 1999
-
$213.80 M(-1.1%)
June 1999
-
$216.10 M(-2.6%)
Mar 1999
$221.90 M(+14.0%)
$221.90 M(+0.1%)
Dec 1998
-
$221.70 M(+5.3%)
Sept 1998
-
$210.50 M(+5.7%)
June 1998
-
$199.20 M(+2.3%)
Mar 1998
$194.70 M(-13.6%)
$194.70 M(-11.1%)
Dec 1997
-
$219.10 M(-5.3%)
Sept 1997
-
$231.40 M(+1.4%)
June 1997
-
$228.20 M(+1.3%)
Mar 1997
$225.30 M(+3.8%)
$225.30 M(-3.5%)
Dec 1996
-
$233.50 M(-0.7%)
Sept 1996
-
$235.10 M(+4.1%)
June 1996
-
$225.90 M(+4.1%)
Mar 1996
$217.00 M(+12.3%)
$217.00 M(+1.0%)
Dec 1995
-
$214.90 M(+4.2%)
Sept 1995
-
$206.20 M(+4.4%)
June 1995
-
$197.50 M(+2.2%)
Mar 1995
$193.20 M(+20.1%)
$193.20 M(+3.5%)
Dec 1994
-
$186.60 M(+3.6%)
Sept 1994
-
$180.10 M(+5.1%)
June 1994
-
$171.30 M(+6.5%)
Mar 1994
$160.80 M(+26.9%)
$160.80 M(+7.4%)
Dec 1993
-
$149.70 M(+4.7%)
Sept 1993
-
$143.00 M(+7.2%)
June 1993
-
$133.40 M(+5.3%)
Mar 1993
$126.70 M(+39.8%)
$126.70 M(+9.4%)
Dec 1992
-
$115.80 M(+4.9%)
Sept 1992
-
$110.40 M(+10.3%)
June 1992
-
$100.10 M(+10.5%)
Mar 1992
$90.60 M
$90.60 M(+10.0%)
Dec 1991
-
$82.40 M(+7.9%)
Sept 1991
-
$76.40 M(+4.1%)
June 1991
-
$73.40 M

FAQ

  • What is Haemonetics annual stockholders equity?
  • What is the all time high annual shareholders equity for Haemonetics?
  • What is Haemonetics annual shareholders equity year-on-year change?
  • What is Haemonetics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Haemonetics?
  • What is Haemonetics quarterly shareholders equity year-on-year change?

What is Haemonetics annual stockholders equity?

The current annual shareholders equity of HAE is $959.96 M

What is the all time high annual shareholders equity for Haemonetics?

Haemonetics all-time high annual stockholders equity is $959.96 M

What is Haemonetics annual shareholders equity year-on-year change?

Over the past year, HAE annual stockholders equity has changed by +$141.96 M (+17.35%)

What is Haemonetics quarterly stockholders equity?

The current quarterly shareholders equity of HAE is $878.85 M

What is the all time high quarterly shareholders equity for Haemonetics?

Haemonetics all-time high quarterly stockholders equity is $959.96 M

What is Haemonetics quarterly shareholders equity year-on-year change?

Over the past year, HAE quarterly stockholders equity has changed by -$14.81 M (-1.66%)